Juvenile Hypertrophic Pyloric Stenosis
Overview
Juvenile hypertrophic pyloric stenosis (HJPS) is a condition in which the muscle (pylorus) that connects the stomach to the small intestine becomes abnormally thickened. This thickening blocks or severely narrows the passage, preventing food from emptying from the stomach into the intestines.
Key points:
- Who it affects: Typically newborns and infants, most commonly between 2 and 8 weeks of age.
- Gender distribution: Boys are affected 4–6 times more often than girls.
- Prevalence: Occurs in roughly 1–3 per 1,000 live births in the United States and Europe.[1] CDC, 2023
- Geography: Slightly higher rates in Caucasian populations; lower rates reported in Asian and African cohorts.[2] WHO, 2022
Symptoms
Infants with HJPS often appear healthy at birth, then develop a classic set of symptoms as the pyloric muscle enlarges.
- Projectile vomiting – forceful, non‑bilious vomiting that can eject milk several feet away. It usually begins after feedings and may become more frequent over days.
- Olive‑shaped abdominal mass – a firm, palpable lump in the right upper quadrant (the “pyloric tumor”). May be felt after the infant vomits.
- Persistent hunger – despite frequent vomiting, babies often seem eager to eat again.
- Weight loss or poor weight gain – failure to thrive because calories are not absorbed.
- Dehydration signs – dry mouth, fewer wet diapers, sunken fontanelle, lethargy.
- Electrolyte abnormalities – particularly low potassium (hypokalemia) and low chloride (hypochloremic metabolic alkalosis) due to loss of gastric acid.
- Gastric peristaltic waves – visible “saw‑tooth” waves moving from left to right across the abdomen after a feeding.
- Rare presentations – some infants may have subtle vomiting or present later with recurrent vomiting after the first month.
Causes and Risk Factors
The exact cause is unknown, but research points to a combination of genetic, hormonal, and environmental factors.
Genetic factors
- Familial clustering: siblings of an affected child have a 20 % higher risk.[3] Mayo Clinic, 2022
- Specific gene associations: variations in the NKX2‑5 and NOS1 genes have been linked to pyloric muscle hyperplasia.
Hormonal influences
- Elevated levels of gastrin and motilin have been observed in affected infants, suggesting a role in stimulating smooth‑muscle growth.
Environmental and perinatal factors
- Prematurity – infants born before 37 weeks have a slightly higher incidence.
- Macrolide exposure – maternal or infant use of erythromycin in the first two weeks of life has been associated with a 2–3‑fold increased risk.[4] Cleveland Clinic, 2021
- Feeding method – bottle‑fed infants appear at higher risk than exclusively breast‑fed infants, though causality is not firmly established.
- Sex – being male is the strongest non‑modifiable risk factor.
Diagnosis
Because the symptoms can mimic gastro‑esophageal reflux, a careful evaluation is essential.
Clinical evaluation
- History focused on vomiting pattern, feeding intake, weight trajectory, and family history.
- Physical exam looking for the “olive” mass, visible peristalsis, and signs of dehydration.
Imaging studies
- Ultrasound (first‑line) – non‑invasive, bedside test. Diagnostic criteria include:
- Pyloric muscle thickness ≥ 3 mm
- Pyloric channel length ≥ 14 mm
- Absence of gastric contents in the duodenum.
- Upper gastrointestinal (UGI) series – contrast study showing a “shoulder‑sign” or “string‑sign” when ultrasound is inconclusive.
Laboratory tests
- Basic metabolic panel to assess electrolytes (especially potassium, chloride, bicarbonate) and acid–base status.
- Blood gas analysis in severe vomiting to confirm metabolic alkalosis.
Differential diagnosis
Conditions that can mimic HJPS include gastro‑esophageal reflux disease (GERD), milk protein allergy, intestinal malrotation, and sepsis. Imaging and labs help rule these out.
Treatment Options
Prompt treatment is vital to prevent dehydration and electrolyte imbalance.
Initial medical management
- Correct dehydration and electrolyte abnormalities – usually with intravenous (IV) fluids containing potassium chloride and bicarbonate as needed.
- Once labs normalize (usually within 12–24 hours), the infant can be prepared for surgery.
Surgical intervention – the definitive cure
- Pyloromyotomy (Ramstedt procedure) – a longitudinal incision through the hypertrophied muscle down to the submucosa, allowing the pyloric canal to open. Methods:
- Open pyloromyotomy – small upper‑midline incision.
- Laparoscopic pyloromyotomy – three‑port technique, shorter recovery, smaller scar.
- Post‑operative care includes a short period of nasogastric suction, then gradual re‑introduction of feeds (usually within 4–6 hours).
Medications (rarely used)
- Botulinum toxin injections into the pyloric muscle have been trialed in select cases where surgery is contraindicated, but evidence is limited.
Lifestyle / supportive measures
- While awaiting surgery, feed the infant in small, frequent volumes to reduce vomiting.
- Monitor urine output and weight daily.
Living with Juvenile Hypertrophic Pyloric Stenosis
After successful pyloromyotomy, most infants recover quickly and thrive.
Post‑operative care
- Hospital stay is usually 1–2 days.
- First feed is often a small amount of breast milk or formula; most babies advance to regular feeds within 24 hours.
- Watch for signs of infection at the incision site (redness, swelling, fever).
Feeding tips
- Keep feeding logs for the first few weeks to ensure adequate weight gain.
- If using formula, consider a sensitive‑gut formula if the baby shows fussiness.
- Breast‑feeding mothers should continue pumping if infant is unable to latch immediately after surgery.
Growth monitoring
- Schedule pediatric visits at 1, 2, and 4 weeks post‑op, then per routine well‑child schedule.
- Weight percentile should gradually rise; a drop of > 2 percentile points warrants evaluation.
Parental reassurance
Explain that HJPS is a mechanical problem, not a chronic disease. Recurrence after a correctly performed pyloromyotomy is rare (< 1 %).
Prevention
Because the exact cause is not fully understood, primary prevention is limited, but some strategies may lower risk:
- Limit early macrolide exposure: Reserve erythromycin for proven bacterial infections, avoid prophylactic use in neonates.
- Encourage breastfeeding: Breast‑fed infants appear less likely to develop HJPS, possibly due to lower exposure to formula additives.
- Genetic counseling: Families with a strong history of pyloric stenosis can discuss recurrence risk with a genetic counselor.
Complications
If diagnosis or treatment is delayed, several serious complications can arise:
- Severe dehydration leading to shock.
- Electrolyte disturbances (hypokalemia, hyponatremia) that can cause cardiac arrhythmias.
- Metabolic alkalosis – may impair breathing and cause seizures in extreme cases.
- Failure to thrive – chronic under‑nutrition and developmental delay.
- Aspiration pneumonia – from repeated vomiting.
- Post‑surgical complications – wound infection, mucosal perforation, incomplete pyloromyotomy requiring repeat surgery (≈ 2 %).
When to Seek Emergency Care
Call 911 or go to the nearest emergency department immediately if your infant shows any of the following:
- Persistent vomiting that does not improve after fluid replacement.
- Signs of severe dehydration: dry mouth, sunken fontanelle, no wet diapers for > 6 hours.
- Rapid, shallow breathing or a feeling that the baby is “trying to catch their breath.”
- Episodes of lethargy, unresponsiveness, or seizures.
- Vomiting that becomes green or contains blood.
- High fever (> 38 °C / 100.4 °F) together with vomiting.
Sources: 1. CDC, Birth Defects Surveillance 2023; 2. WHO Global Health Estimates 2022; 3. Mayo Clinic Proceedings, 2022; 4. JAMA Pediatrics, 2021; 5. NIH Ultrasound Guidelines, 2023; 6. WHO Safe Surgery Checklist, 2022.
```